NVT is a company that, develops, manufactures and markets minimally invasive medical products for interventional cardiologists and cardiac surgeons for the treatment of heart valve diseases. The NVT Allegra TAVI System is a catheter based transfemoral aortic valve implantation system for the treatment of severe calcified aortic stenosis in high surgical risk patients.
Aortic valve stenosis is the most common valvar disease in industrialized countries. The predominant cause of this disease are degenerative changes. Accordingly, aortic valve stenosis is generally a disease of the elderly; typical symptoms are shortness of breath and loss of consciousness. Due to the elevated stress the heart muscle is also damaged chronically. Aortic valve replacement is the only possible treatment option for most patients. Many elderly patients with aortic stenosis requiring surgical valve replacement cannot undergo this procedure due to high surgical risk. In a transcatheter aortic valve implantation (TAVI) the new valve is delivered crimped inside a catheter to the implantation site through the vasculature and released at the position of the native aortic valve, avoiding open heart surgery and reducing the operative risk.
The NVT Allegra TAVI System is used to treat high-risk patients with aortic stenosis. From heart to heart.Learn more about
NVT stands for quality and the highest technical standards. The products are produced exclusively in Germany and thus support the regional economy.Learn more about
The patented PermaFlow principle allows for stable hemodynamics at all times during the implantation.Learn more about
Quality made in Germany
NVT products are produced to the highest technical standards and create jobs in the region.